HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy

As PI3K/Akt signaling is frequently deregulated in a wide variety of human tumors, PI3K inhibitors are an emerging class of drugs for cancer treatment. The monitoring of the drug behavior and distribution in the biological system can play an important role for targeted therapy and provide informatio...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Lee, Ju-Hee, Jung, Kyung Hee, Lee, Hyunseung, Son, Mi Kwon, Yun, Sun-Mi, Ahn, Sung-Hoon, Lee, Kyeong-Ryoon, Lee, Soyoung, Kim, Donghee, Hong, Sungwoo, Hong, Soon-Sun
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2014
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259414/
https://ncbi.nlm.nih.gov/pubmed/25338206
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk